Cleared Traditional

K231323 - Ancora-SB (FDA 510(k) Clearance)

Aug 2023
Decision
115d
Days
Class 2
Risk

K231323 is an FDA 510(k) clearance for the Ancora-SB. This device is classified as a Enteroscope And Accessories (Class II - Special Controls, product code FDA).

Submitted by Aspero Medical, Inc. (Fort Collins, US). The FDA issued a Cleared decision on August 31, 2023, 115 days after receiving the submission on May 8, 2023.

This device falls under the Gastroenterology & Urology FDA review panel. Regulated under 21 CFR 876.1500. To Provide Visualization And Perform Various Procedures Within The Small Intestine. For Reusable, Flexible Endoscopes In This Product Code, Validated Reprocessing Instructions And Reprocessing Validation Data Must Be Included In A 510(k) Submission (82 Fr 26807, Available At Https://www.gpo.gov/fdsys/pkg/fr-2017-06-09/pdf/2017-12007.pdf)..

Submission Details

510(k) Number K231323 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 08, 2023
Decision Date August 31, 2023
Days to Decision 115 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF

Device Classification

Product Code FDA - Enteroscope And Accessories
Device Class Class II - Special Controls
CFR Regulation 21 CFR 876.1500
Definition To Provide Visualization And Perform Various Procedures Within The Small Intestine. For Reusable, Flexible Endoscopes In This Product Code, Validated Reprocessing Instructions And Reprocessing Validation Data Must Be Included In A 510(k) Submission (82 Fr 26807, Available At Https://www.gpo.gov/fdsys/pkg/fr-2017-06-09/pdf/2017-12007.pdf).